 Bank of New York Mellon Corp bought a new position in shares of Oyster Point Pharma NASDAQ:OYST in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission SEC. The fund bought 10,505 shares of the companys stock, valued at approximately 257,000. A number of other ... 